Janux Therapeutics market cap JANX
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Nov 2, 2026
- $1.1B
- Highest close in our data
- $3.4B
- Dec 2024
Janux Therapeutics is worth $1.1B at the close on Nov 2, 2026, at $17.46 a share.
That is down 33% over the last year and down 6% over five years.
Its highest close in our data was $3.4B in Dec 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.1B | $786.1M | $1.2B | +25% |
| 2025 | $857.1M | $829.4M | $2.8B | −70% |
| 2024 | $2.8B | $384.1M | $3.4B | +473% |
| 2023 | $495.4M | $277.8M | $916.6M | −10% |
| 2022 | $548.7M | $409.6M | $769.8M | −33% |
| 2021 | $821M | $667.4M | $1.4B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Janux Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| JANXJanux Therapeutics | $1.1B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.3B |
| ANABAnaptysbio | $1.4B |
| ABUSArbutus Biopharma | $791.4M |
| PCRXPacira BioSciences | $1.5B |
| COLLCollegium Pharmaceutical | $770.9M |
| PAHCPhibro Animal Health | $1.6B |
| ANIPANI Pharmaceuticals | $1.6B |
| ZVRAZevra Therapeutics | $599.8M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| Peer median | $1.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Janux Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.